• Return to Headlines

Lowest Free Cash Flow Per Share in the Biotechnology Industry Detected in Shares of Opko Health (OPK, MNTA, FGEN, MDXG, PGNX)

By Amy Schwartz

Below are the three companies in the Biotechnology industry with the lowest (positive) free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.

Opko Health ranks lowest with a FCF per share of $0.02. Momenta Pharmace is next with a FCF per share of $0.03. Fibrogen Inc ranks third lowest with a FCF per share of $0.09.

Mimedx Group Inc follows with a FCF per share of $0.18, and Progenics Pharm rounds out the bottom five with a FCF per share of $0.21.

SmarTrend recommended that its subscribers protect gains by selling shares of Mimedx Group Inc on February 16th, 2018 by issuing a Downtrend alert when the shares were trading at $14.64. Since that call, shares of Mimedx Group Inc have fallen 52.2%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest free cash flow per share opko health momenta pharmace fibrogen inc mimedx group inc progenics pharm

Ticker(s): OPK MNTA FGEN MDXG PGNX